ClinPGx 2024 Meeting

June 20-21, 2024
University of Pennsylvania
Philadelphia, PA

Session 1: Why PGx (Justification as to why we are all here)

Opening Remarks
  • Kelly Caudle, PharmD, PhD - St. Jude Children’s Research Hospital
Stevens Johnson Syndrome and Implementation of HLA Testing
  • Sony Tuteja, PharmD, MS - Penn Center for Precision Medicine, University of Pennsylvania
Physician’s View: Stevens Johnson Syndrome
  • Teri Manolio, MD, PhD - National Human Genome Research
Representative View: Stevens Johnson Syndrome
  • Paul Anderson – parent of Angela Anderson

Session 2: Implementation Strategies (Justification as to how we are doing this)

VA National Pharmacogenomics Program: PGx Implementation in the Veterans Health Administration
  • Deepak Voora, MD - Durham Veterans Affairs Medical Center
Implementing CYP3A5 and Tacrolimus`
  • Amy Pasternak, PharmD – University of Michigan, College of Pharmacy
Implementation of Clinical Pharmacogenomics Across a Multi-State Health System
  • Natasha Petry, PharmD, MPH - Sanford Health Imagenetics
State of the Art with Clinical Labs and Implementers: A Panel Discussion
  • Kristine Crews, PharmD - St. Jude Children’s Research Hospital
  • Mark Dunnenberger, PharmD - Endeavor Health

Session 3: Regulatory Hurdles and the Path Forward

Legislation Efforts in Pharmacogenomics
  • Kristine Ashcraft, BS, MBA – YouScript
Challenges and Opportunities in Regulating Pharmacogenomics
  • Don Rule - Translational Software
The All of Us Experience
  • Phil Empey, PharmD, PhD - University of Pittsburgh

Session 4: PGx Resources

The Pharmacogene Variation Consortium (PharmVar) – New Content and Features
  • Andrea Gaedigk, PhD – Children’s Mercy Research Institute
Clinical Pharmacogenetics Implementation Consortium (CPIC)
  • Kelly Caudle, PharmD, PhD - St. Jude Children’s Research Hospital
Pharmacogenomics Knowledgebase (PharmGKB) and Pharmacogenomics Clinical Annotation Tool (PharmCAT)
  • Michelle Whirl-Carrillo, PhD – Stanford University
Clinical Pharmacogenomics (ClinPGx) and Clinical Genome Resource (ClinGen)
  • Teri E. Klein, PhD – Stanford University

Session 5: Use of AI and LLMs to Improve Precision Health

Leveraging Electronic Health Record Data for Targeted Detection of Cognitive Impairment
  • Kyra O’Brien, MD – Penn Memory Center, University of Pennsylvania
AI & Oncology: Managing the Tsunami of Medical Information
  • David Penberthy, MD, MBA - University of Virginia
Explainable AI for Health: Where We Are and How to Move Forward
  • Su-In Lee, PhD - University of Washington

Session 6: Advancing Pharmacogenomics Education Across the Spectrum of Clinician

Beginning at the Beginning: Preparing Students in Pharmacy and Medical Schools to Become Leaders in Pharmacogenomics
  • Kristin Wiisanen, PharmD - Rosalind Franklin of Medicine and Science
Equipping Residents and Fellows to Deliver the Future of Precision Medicine
  • Kristine Crews, PharmD - St. Jude Children’s Research
Improving the Genomic Literacy of Healthcare Professionals Through the Inter-Society Coordinating Committee for Practitioner Education in Genomics (ISCC-PEG)
  • Roseann Donnelly, PharmD, FCCP, BCPS - Massachusetts College of Pharmacy and Health Sciences

Session 7: Recent Developments from the Clinical Labs and EHR & Closing

AMP’s Recommendations for Clinical Pharmacogenotyping Allele Selection
  • Victoria Pratt, PhD, FACMG - Indiana University School of Medicine
Development of In-house PGx Testing at Children’s Mercy
  • Laura Ramsey, PhD - Children’s Mercy
Using the EHR for PGx and Closing Remarks
  • Marylyn Ritchie, PhD - University of Pennsylvania, Perelman School of Medicine